NEWS / NOTICE
Caregen Reports 4Q and FY2020 Results
Caregen signs MOU with Knotus for veterinary business
Caregen signs a exclusive agreement with BASF
Caregen holds Symposium on Decentralized Peptide at IMCAS
Caregen, blood sugar-regulated peptide dry type approval for..
Caregen holds Global Partners Day event
Caregen, presents cosmetics botulinum toxin at IMCAS
ABOUT US
Global No 1.
Peptide-Based
Biotechnology Company
Caregen is a global leading company infra-structured
with world class technology in the field of biomimetic peptide synthesis.
